Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

PLXPLX
Showing 8 of 13 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in PROTALIX BIOTHERAPEUTICS INC

NORTHERN TRUST CORP holds 922,340 shares of PLX (PROTALIX BIOTHERAPEUTICS INC), worth $2.1M as of 2026-Q2. The position was increased (+4.2% shares). PLX represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$2.1M

Current Shares

922,340

Total Value Change

+$2.1M

Total Shares Change

+870,049

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
922,340
+4.2%
$2.1M0.0%$2.33
27
2026-Q1
Increased
885,448
+2.3%
$1.9M0.0%$2.83
26
2025-Q4
Decreased
865,708
-4.1%
$1.6M0.0%$1.74
0
2025-Q3
Decreased
902,459
-16.4%
$2M0.0%$2.16
0
2025-Q2
Increased
1.1M
+57.7%
$1.6M0.0%$1.54
37
2025-Q1
Decreased
684,758
-6.4%
$1.8M0.0%$2.58
0
2024-Q4
Increased
731,742
+1299.4%
$1.4M0.0%$1.89
41
2024-Q3
Decreased
52,291
-87.6%
$53,3360.0%$1.05
0

Other major holders of PLX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used